SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001626199-19-000035
Filing Date
2019-04-24
Accepted
2019-04-24 17:27:43
Documents
5
Effectiveness Date
2019-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a.htm DEFA14A 29244
2 proxynotice2019001.jpg GRAPHIC 95358
3 proxynotice2019002.jpg GRAPHIC 125427
4 proxynotice2019003.jpg GRAPHIC 45276
5 proxynotice2019004.jpg GRAPHIC 27187
  Complete submission text file 0001626199-19-000035.txt   434594
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37449 | Film No.: 19764703
SIC: 2834 Pharmaceutical Preparations